Context Therapeutics is trading at $0.67, up 12.7% from a comparison close of $0.59 during regular trading. This is a price-action follow-up, so a separate catalyst may not be included.
🟢 Context Therapeutics is trading 12.7% up
Context Therapeutics Inc
Related News
CNTX
Context Therapeutics Reports Positive Phase 1 Data for CTIM-76 in Ovarian Cancer
CNTX
🔴 Context Therapeutics falls 5.7% — Biotech Sector Declines on Macro Fears and Key Stock Weakness
CNTX
Context Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 11, 2026
CNTX
🟢 Context Therapeutics rises 6.0% — Biotech Sector Rallies on Positive Trial Data and M&A News
CNTX